Literature DB >> 32659300

Phytochemical and pharmacological properties of asperuloside, a systematic review.

Maria Giulia Manzione1, Miquel Martorell2, Farukh Sharopov3, Namrata Ganesh Bhat4, Nanjangud Venkatesh Anil Kumar5, Patrick Valere Tsouh Fokou6, Raffaele Pezzani7.   

Abstract

Plants are a natural source of bioactive compounds such as secondary metabolites. These molecules, also called phytochemicals, are fundamental for plant survival and often show therapeutic properties used for the treatment of human diseases. Asperuloside is a secondary metabolite which belongs to iridoid glycosides and is commonly present in the plant family Rubiaceae. In this review we aim to summarize the scientific knowledge on asperuloside, with a special emphasis on its pharmacological properties as anti-viral, anti-malarial, anti-protozoal, anti-tumorigenic, anti-hypertensive, anti-obesity, immunomodulatory, anti-inflammatory and antioxidant agent. Preclinical studies in animal models suggest that asperuloside has therapeutic potential that could be evaluated in humans. However, despite its tangible phytochemical characteristics, no clinical trial has been performed so far. Thus, we hope that this review will facilitate scientific dissemination of asperuloside pharmacological properties and encourage researchers to evaluate both pharmacokinetic and toxicity of asperuloside in animal models. This will be the first step towards clinical studies in humans.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asperuloside; Iridoid glycosides; Rubiaceae

Mesh:

Substances:

Year:  2020        PMID: 32659300     DOI: 10.1016/j.ejphar.2020.173344

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Evaluation of the Antioxidant, Anti-Inflammatory and Cytoprotective Activities of Halophyte Extracts against Mycotoxin Intoxication.

Authors:  Nolwenn Hymery; Xavier Dauvergne; Halima Boussaden; Stéphane Cérantola; Dorothée Faugère; Christian Magné
Journal:  Toxins (Basel)       Date:  2021-04-27       Impact factor: 4.546

2.  Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.

Authors:  Si-Jing Hu; Gang Cheng; Hao Zhou; Qi Zhang; Quan-Long Zhang; Yang Wang; Yi Shen; Chen-Xia Lian; Xue-Qin Ma; Qiao-Yan Zhang; Lu-Ping Qin
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.